All acute myeloid leukaemia articles
-
ArticleWhy researchers are revisiting bisantrene decades after it was abandoned
An oncology drug abandoned decades ago is getting a second look, with new research uncovering a mechanism that could offer an alternative route to targeting MYC, one of cancer’s toughest targets.
-
NewsLeukaemia cells hit hard by innovative dual-drug approach
Scientists have discovered a dual-drug therapy that dramatically increases leukaemia cell death, offering new hope for patients with acute myeloid leukaemia (AML). By combining SRC and MCL-1 inhibitors, this approach opens the door to more effective treatments.